Full-Body Haptic Exosuit: Micro-Stimulation Architecture for Mobility Restoration and Muscle Maintenance in Spinal Cord Injury

TimeLord (novel combinations of original ideas)
2026-02-22
spinal cord injury functional electrical stimulation haptic exosuit muscle atrophy prevention sarcomere maintenance neuromuscular junction wearable rehabilitation micro-stimulation high-frequency interference exoskeleton

Abstract

Spinal cord injury produces two parallel injury processes: the primary lesion (axonal disruption preventing motor command transmission) and secondary muscle denervation atrophy (progressive sarcomere loss, neuromuscular junction degradation, and type I-to-II fiber conversion that compounds the primary disability). Current functional electrical stimulation (FES) approaches address the second process incompletely: single-channel surface stimulation produces rapid fatigue, recruits superficial fibers non-selectively, and cannot achieve the deep muscle penetration required for sustained tonic maintenance. We describe a full-body haptic exosuit delivering continuous sub-perceptual electrical micro-stimulation across all major muscle groups via a 256-electrode garment worn under clothing. The stimulation uses high-frequency interference patterns -- constructive wavefronts from multiple electrode pairs that create deep-tissue recruitment without the surface-level discomfort of conventional FES. The suit operates in two modes: (1) passive maintenance -- tonic micro-stimulation at minimum contractile threshold to preserve sarcomere integrity and neuromuscular junction viability; (2) active rehabilitation -- patterned stimulation sequences encoding voluntary motor programs from the Arc headband, enabling progressive motor re-education. At manufacturing scale, the suit costs $1,200-3,500. Released under the GPL-3.0 as open prior art.

1. Introduction

1.1 The Secondary Injury Nobody Fixes

The spinal cord injury rehabilitation field correctly focuses on the primary injury -- the lesion. But while rehabilitation teams address the cord, the muscles below the lesion are quietly dying.

Skeletal muscle requires two things to survive: neural trophic support (axonal contact at the neuromuscular junction releasing BDNF, CNTF, and IGF-1 that maintain sarcomere protein turnover) and mechanical loading (tension-sensitive signaling via titin, integrin complexes, and mTORC1 activation that triggers muscle protein synthesis). SCI eliminates both simultaneously.

The result is predictable: within 6 weeks of complete injury, muscle cross-sectional area begins declining at 3-6% per week in the acute phase. Over years, this produces the characteristic lower limb muscle morphology of long-duration SCI: atrophic, largely replaced by intramuscular fat, with neuromuscular junctions that have partially retracted. Type I slow-twitch fibers (fatigue-resistant, oxidative) convert to type II fast-twitch (glycolytic, fatigue-prone), further limiting any rehabilitation potential.

For a patient injured decades ago, this process has run to near-completion in the muscles below the lesion. The muscles are not gone -- but they are substantially compromised. Any restoration of function (through the Arc headband, through exoskeleton, through future cord repair) will land on a muscle substrate that has been neglected for decades.

1.2 Current FES Limitations

Conventional FES uses surface electrodes (2-4 per muscle group) delivering biphasic pulses at 20-50 Hz. Limitations:

1.3 High-Frequency Interference: The Physics

The high-frequency interference (HFI) approach addresses limitations 1, 3, and 4 simultaneously. The principle: two high-frequency carrier signals (e.g., 4 kHz and 4.1 kHz) are delivered through electrode pairs positioned on opposite sides of the target muscle. Individually, each carrier is above the frequency range of neural activation (action potentials cannot follow >1 kHz continuously). But where the two wavefronts intersect inside the tissue, they produce a beat frequency (4,100 - 4,000 = 100 Hz) -- which is within the neural activation range and which selectively activates the motor units at the interference focus.

Result: stimulation occurs deep in the tissue at the geometric intersection of the two beams, not at the skin surface. Surface current density is sub-threshold; the interference node is at threshold. This is the same principle used in interferential current therapy (IFC) for pain management, now applied with precision electrode placement for deep motor unit recruitment.

Extensions:

2. Suit Architecture

2.1 Garment Design

The suit is a two-piece lycra-spandex garment (upper body: long-sleeve top; lower body: full-leg tights) incorporating 256 electrode sites in a printed conductive textile pattern. Materials:

2.2 Stimulator Unit

The stimulator unit generates:

2.3 Electrode Coverage Map

256 electrodes cover:

3. Stimulation Protocols

3.1 Passive Maintenance Mode

Goal: minimum contractile threshold stimulation sufficient to maintain sarcomere integrity and NMJ viability without producing observable movement or patient discomfort.

Parameters:

Evidence basis: animal denervation studies demonstrate that as little as 8-12 Hz tonic electrical stimulation at sub-threshold levels is sufficient to prevent the type I → type II fiber conversion and maintain NMJ morphology. In humans, even low-dose passive stimulation in acute SCI (within 6 weeks) attenuates the atrophy trajectory significantly. The maintenance protocol targets the minimum effective dose for maximum long-term wearability.

3.2 Active Rehabilitation Mode

Triggered by Arc headband motor intent decoding or by scheduled rehabilitation session:

3.3 Autonomic Applications

For complete cervical SCI patients, autonomic dysreflexia (AD) -- sudden dangerous hypertension triggered by stimuli below the lesion -- is a life-threatening complication. The suit can serve as an early detection and intervention platform:

4. Integration with Arc Headband

The suit and headband form a closed sensorimotor loop: 

[Arc: OPM motor intent decode] → [Intent signal: "stand"]


    ↓
[Suit stimulator: activate stand program]
    ↓
[Quadriceps + gluteus stimulation → joint torque → stance]
    ↓
[Exoskeleton provides structural support]
    ↓
[OPM: detect motor cortex execution signal confirmation]
    ↓
[Classifier: label as successful → update model]

The critical design principle: the suit provides the peripheral execution that the cord cannot. The headband provides the central intent that the patient generates. The cord lesion is bridged not by repairing it but by routing around it: cortex → air-gap (radio) → periphery.

For patients with intact sensation below the lesion (incomplete SCI), proprioceptive feedback from the suit-driven movement reaches the cortex through preserved posterior column pathways, closing the sensorimotor loop neurologically and accelerating motor learning.

5. Manufacturing Cost Analysis

At prototype scale:

At manufacturing scale (10,000+ units/year):

6. Clinical Evidence Basis and Projected Outcomes

6.1 Existing FES Evidence

Meta-analysis of FES in chronic SCI (>1 year post-injury):

These outcomes are from conventional FES. HFI-based stimulation has been shown in acute studies to achieve equivalent or superior muscle force production at significantly lower surface current density -- projecting to better compliance and longer achievable treatment duration.

6.2 Projected Suit Outcomes (3-year program)

Based on FES literature extrapolated to full-body continuous maintenance dose:

For patients injured decades ago: outcomes attenuated but positive. Any improvement in muscle bulk directly reduces pressure sore risk (the leading cause of hospitalization and death in chronic SCI), reduces caregiver burden for daily hygiene, and improves the substrate available for Arc-driven functional movement.

7. Conclusion

The secondary injury of SCI -- muscle denervation atrophy -- is largely preventable with technology that already exists. The haptic exosuit converts that technology from clinical FES equipment requiring technician operation to a wearable garment worn under clothing, providing continuous maintenance with zero daily burden on patient or caregiver.

At manufacturing scale, the annual cost of the suit is equivalent to three days of professional attendant care. The clinical case for deployment is unambiguous. The barrier, again, is not physics.

Released under the GPL-3.0. Build it.

References

Authorship and Funding

Funding: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. This is a design specification based on published evidence and does not represent new experimental work.

Conflict of Interest: None declared.

Data Availability: This paper presents no original data. All performance parameters are extrapolated from published literature cited in the references. All design specifications are provided in full within the text.

License: GPL-3.0 Prior art date: 2026-02-22

GPL-3.0
© 2025–2026 TimeLord |  github.com/TimeLordRaps/race-to-walk-again
Open Source — Non-exclusive, open, forever.